全球生物数据视觉化市场

到 2030 年，全球生物数据视觉化市场规模将达到 21 亿美元

全球生物数据视觉化市场规模预计在2024年为13亿美元，预计到2030年将达到21亿美元，2024年至2030年的复合年增长率为7.8%。定序是本报告分析的细分市场之一，预计其复合年增长率为7.9%，到分析期结束时规模将达到8.145亿美元。显微镜细分市场在分析期间内的复合年增长率预计为7.8%。

美国市场规模估计为 3.432 亿美元，中国市场预计复合年增长率为 11.9%

美国生物数据视觉化市场规模预计在2024年达到3.432亿美元。作为世界第二大经济体，中国预计在2030年市场规模将达到5.366亿美元，在分析期间（2024-2030年）的复合年增长率为11.9%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为3.4%和6.7%。在欧洲，预计德国的复合年增长率为4.3%。

全球生物数据视觉化市场—主要趋势与驱动因素摘要

科技进步将如何改变生物数据的可视化？

数据分析和视觉化工具的技术进步彻底改变了生物数据视觉化市场，使研究人员能够更准确、更快速地解读复杂的数据集。生物数据视觉化以图形方式呈现基因序列、蛋白质结构和分子相互作用等生物数据，从而加深对生物过程和疾病机制的理解。巨量资料分析、人工智慧 (AI) 和机器学习 (ML) 领域的最新创新正在提升处理大量生物数据和产生有意义的视觉洞察的能力。高效能运算 (HPC) 平台和云端基础的视觉化工具进一步提高了生物数据分析的可存取性和可扩展性，使研究人员能够即时进行全球计划协作。数据视觉化软体中人工智慧驱动演算法的整合实现了模式识别和预测建模的自动化，帮助研究人员更快地识别重要的生物学趋势和关係。这些进步正在改变科学家分析生物数据的方式，促进更准确、更有效率的药物研发、基因组学研究和个人化医疗工作。

为什么生物数据可视化在生命科学中变得至关重要？

生物数据视觉化在生命科学领域变得越来越重要，现代研究技术产生的数据量和复杂性正呈指数级增长。基因组学、蛋白质组学、代谢体学研究和药物研发会产生大量数据，需要先进的视觉化技术才能揭示有意义的见解。视觉化工具透过将复杂的生物数据以图形形式呈现，使研究人员能够识别仅使用原始数据难以发现的模式、关係和异常。这在基因组学和蛋白质组学中尤其重要，因为基因组学使用视觉化工具来绘製和比较基因序列，而蛋白质组学则可以将蛋白质结构和相互作用可视化。此外，生物数据视觉化在个人化医疗的发展中也发挥关键作用，因为必须分析患者特定数据，才能根据个别基因图谱制定个人化治疗方案。随着生命科学领域的发展，生物数据视觉化已成为开启新发现和加速科学进步的关键。

产业和医疗保健趋势如何影响生物数据视觉化市场？

生物数据视觉化市场正受到医疗保健和生命科学产业几大关键趋势的影响，尤其是对个人化医疗的日益关注和多组体学研究的兴起。随着个人化医疗的持续普及，对复杂数据视觉化工具的需求也日益凸显。研发人员和临床医生需要分析大型复杂资料集，例如基因组序列、蛋白质体学谱和临床记录，以识别独特的生物标记并制定针对个别患者的个人化治疗方法。这种向数据驱动的个人化医疗保健的转变，推动了对能够处理和解读患者特定数据的先进生物数据视觉化解决方案的需求。此外，整合基因组学、蛋白质组学、转录组学、代谢体学等数据的多体学方法的日益普及，进一步增加了生物数据分析的复杂性。能够以连贯且可解释的方式整合和显示此类多层数据集的视觉化工具，对于推进研究和改善临床结果至关重要。

哪些因素推动了生物数据视觉化市场的成长？

生物数据视觉化市场的成长受到多种因素的推动，包括生物学研究日益复杂、数据分析技术的进步以及个人化医疗角色的不断扩大。其中一个主要因素是基因组学和多组体学研究的快速发展，这产生了大量数据，需要先进的视觉化工具进行分析。人工智慧和机器学习的兴起也促进了市场的成长，因为这些技术实现了数据分析和模式识别的自动化，使研究人员更容易从复杂的生物数据中获得见解。此外，对个人化医疗的日益关注也推动了对视觉化工具的需求，这些工具可以帮助临床医生解读患者特定数据并制定个人化治疗方案。云端运算和高效能运算平台的扩展进一步提高了生物数据视觉化解决方案的可存取性和可扩展性，使研究人员能够在全球范围内合作开展大型计划并共用见解。随着数据主导研究和个人化医疗保健需求的持续成长，生物数据视觉化市场预计将持续成长。

部分

技术（定序、显微镜、磁振造影、X 射线晶体学、其他技术）、应用（细胞/生物成像、结构/分子建模、基因组分析、比对、系统发育/进化、系统生物学）、最终用途（学术研究、製药/生物技术公司、医院/诊所、其他最终用途）

受访公司范例

• 3M
• Advanced Visual Systems, Inc.
• Agilent Technologies
• arivis AG
• Becton, Dickinson and Company（BD）
• Carl Zeiss AG
• Clarivate Analytics
• Danaher
• Genedata AG
• Genialis, Inc.

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 并未遵循典型的 LLM 或特定产业的 SLM查询，而是建立了一个从全球专家收集的内容库，其中包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Biological Data Visualization Market to Reach US$2.1 Billion by 2030

The global market for Biological Data Visualization estimated at US$1.3 Billion in the year 2024, is expected to reach US$2.1 Billion by 2030, growing at a CAGR of 7.8% over the analysis period 2024-2030. Sequencing, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$814.5 Million by the end of the analysis period. Growth in the Microscopy segment is estimated at 7.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$343.2 Million While China is Forecast to Grow at 11.9% CAGR

The Biological Data Visualization market in the U.S. is estimated at US$343.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$536.6 Million by the year 2030 trailing a CAGR of 11.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Biological Data Visualization Market - Key Trends & Drivers Summarized

How Are Technological Innovations Transforming Biological Data Visualization?

Technological advancements in data analytics and visualization tools are revolutionizing the biological data visualization market, enabling researchers to interpret complex datasets with greater precision and speed. Biological data visualization involves the graphical representation of biological data, such as genetic sequences, protein structures, and molecular interactions, to enhance the understanding of biological processes and disease mechanisms. Recent innovations in big data analytics, artificial intelligence (AI), and machine learning (ML) are improving the ability to process large volumes of biological data and generate meaningful visual insights. High-performance computing (HPC) platforms and cloud-based visualization tools are further enhancing the accessibility and scalability of biological data analysis, allowing researchers to collaborate on global projects in real time. The integration of AI-driven algorithms in data visualization software is enabling automated pattern recognition and predictive modeling, helping researchers identify critical biological trends and relationships faster. These advancements are transforming the way scientists analyze biological data, facilitating more accurate and efficient drug discovery, genomics research, and personalized medicine initiatives.

Why Is Biological Data Visualization Becoming Essential in Life Sciences?

Biological data visualization is becoming increasingly essential in the life sciences, where the volume and complexity of data generated by modern research techniques are growing exponentially. Genomics, proteomics, and metabolomics research, as well as drug discovery, generate vast amounts of data that require sophisticated visualization techniques to uncover meaningful insights. By representing complex biological data in a graphical format, visualization tools enable researchers to identify patterns, relationships, and anomalies that would be difficult to detect through raw data alone. This is particularly important in genomics, where visual tools are used to map and compare genetic sequences, and in proteomics, where researchers can visualize protein structures and interactions. Additionally, biological data visualization is playing a critical role in the development of personalized medicine, where patient-specific data must be analyzed to tailor treatments to individual genetic profiles. As the life sciences field continues to advance, biological data visualization is becoming indispensable for unlocking new discoveries and accelerating scientific progress.

How Are Industry and Healthcare Trends Shaping the Biological Data Visualization Market?

The biological data visualization market is being shaped by several key trends in the healthcare and life sciences industries, particularly the increasing focus on personalized medicine and the rise of multi-omics research. As personalized medicine continues to gain traction, the need for sophisticated data visualization tools is becoming more pronounced. Researchers and clinicians must analyze large, complex datasets-such as genomic sequences, proteomic profiles, and clinical records-to identify unique biomarkers and develop tailored therapies for individual patients. This shift toward data-driven, personalized healthcare is driving demand for advanced biological data visualization solutions that can handle and interpret patient-specific data. Moreover, the growing adoption of multi-omics approaches, which integrate data from genomics, proteomics, transcriptomics, and metabolomics, is further increasing the complexity of biological data analysis. Visualization tools that can synthesize and display these multi-layered datasets in a coherent and interpretable manner are becoming critical for advancing research and improving clinical outcomes.

What Factors Are Driving Growth in the Biological Data Visualization Market?

The growth in the biological data visualization market is driven by several factors, including the increasing complexity of biological research, technological advancements in data analytics, and the expanding role of personalized medicine. One of the primary drivers is the rapid growth of genomics and multi-omics research, which generates vast amounts of data that require sophisticated visualization tools to analyze. The rise of AI and machine learning is also contributing to market growth, as these technologies enable the automation of data analysis and pattern recognition, making it easier for researchers to derive insights from complex biological data. Additionally, the growing focus on personalized medicine is driving demand for visualization tools that can help clinicians interpret patient-specific data and develop tailored treatment plans. The expansion of cloud computing and high-performance computing platforms is further enhancing the accessibility and scalability of biological data visualization solutions, enabling researchers to collaborate on large-scale projects and share insights globally. As the demand for data-driven research and personalized healthcare continues to rise, the biological data visualization market is expected to experience sustained growth.

SCOPE OF STUDY:

The report analyzes the Biological Data Visualization market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technique (Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography, Other Techniques); Application (Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis, Alignments, Phylogeny & Evolution, Systems Biology); End-Use (Academic Research, Pharma & Biotech Companies, Hospitals & Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 33 Featured) -

• 3M
• Advanced Visual Systems, Inc.
• Agilent Technologies
• arivis AG
• Becton, Dickinson and Company (BD)
• Carl Zeiss AG
• Clarivate Analytics
• Danaher
• Genedata AG
• Genialis, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Global Economic Update
  • Biological Data Visualization - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Volume of Genomic and Proteomic Data Drives Growth in the Biological Data Visualization Market
  • Technological Advancements in Data Analytics Propel the Use of Visualization Tools in Life Sciences
  • Increasing Adoption of Big Data in Healthcare and Biotechnology Expands Market for Biological Data Visualization
  • Growing Focus on Precision Medicine Fuels Demand for Advanced Visualization Tools in Genomic Research
  • Technological Innovations in 3D and Virtual Reality (VR) Visualization Enhance Interpretation of Complex Biological Data
  • Rising Use of Artificial Intelligence (AI) and Machine Learning (ML) in Biological Data Visualization Expands Capabilities
  • Growing Integration of Cloud Computing and Visualization Software Strengthens Market for Real-Time Data Analysis
  • Increased Adoption of Biological Data Visualization Tools in Drug Discovery and Development Expands Market Scope
  • Technological Developments in Multi-Omics Data Integration Drive Demand for Advanced Visualization Platforms
  • Rising Focus on Collaborative Research and Data Sharing Expands Use of Cloud-Based Visualization Tools in Life Sciences
  • Growing Use of Biological Data Visualization in Clinical Research and Trials Expands Opportunities for Personalized Medicine
  • Increased Adoption of Biological Data Visualization in Agricultural Genomics and Crop Improvement Expands Market
  • Technological Integration of Augmented Reality (AR) with Biological Data Visualization Tools Enhances Research Insights
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Biological Data Visualization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Biological Data Visualization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for Biological Data Visualization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Microscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Microscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for Microscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Magnetic Resonance Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Magnetic Resonance Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 12: World 15-Year Perspective for Magnetic Resonance Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for X-ray Crystallography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 14: World Historic Review for X-ray Crystallography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 15: World 15-Year Perspective for X-ray Crystallography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 18: World 15-Year Perspective for Other Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Systems Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Systems Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 21: World 15-Year Perspective for Systems Biology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Cell & Organism Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Cell & Organism Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 24: World 15-Year Perspective for Cell & Organism Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Structural Biology & Molecular Modeling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Structural Biology & Molecular Modeling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 27: World 15-Year Perspective for Structural Biology & Molecular Modeling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 28: World Recent Past, Current & Future Analysis for Genomic Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 29: World Historic Review for Genomic Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 30: World 15-Year Perspective for Genomic Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 31: World Recent Past, Current & Future Analysis for Alignments, Phylogeny & Evolution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 32: World Historic Review for Alignments, Phylogeny & Evolution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 33: World 15-Year Perspective for Alignments, Phylogeny & Evolution by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 34: World Recent Past, Current & Future Analysis for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 35: World Historic Review for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 36: World 15-Year Perspective for Academic Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 37: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 38: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 39: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 40: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 41: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 42: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 43: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 44: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 45: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 46: World Biological Data Visualization Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• JAPAN
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• CHINA
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• EUROPE
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Biological Data Visualization by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Biological Data Visualization by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Biological Data Visualization by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• FRANCE
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 95: France Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• GERMANY
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 119: Italy Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Italy Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Italy 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 122: UK Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 128: UK Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: UK Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: UK 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 137: Spain Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Spain Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Spain 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 146: Russia Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Russia Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Russia 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Rest of Europe Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Rest of Europe 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Biological Data Visualization by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Biological Data Visualization by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Biological Data Visualization by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Asia-Pacific Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Asia-Pacific 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 176: Australia Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Australia Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Australia 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• INDIA
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 179: India Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 185: India Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: India Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: India 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 194: South Korea Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: South Korea Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: South Korea 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Asia-Pacific Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Biological Data Visualization by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Biological Data Visualization by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Biological Data Visualization by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 215: Latin America Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Latin America Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Latin America 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 224: Argentina Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Argentina Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Argentina 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 233: Brazil Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Brazil Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Brazil 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 242: Mexico Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Mexico Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Mexico 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Latin America Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Latin America 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Biological Data Visualization by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Biological Data Visualization by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Biological Data Visualization by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 263: Middle East Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Middle East Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Middle East 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 272: Iran Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Iran Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Iran 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 281: Israel Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Israel Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Israel 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Saudi Arabia Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Saudi Arabia 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 299: UAE Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: UAE Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: UAE 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Middle East Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Middle East 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• AFRICA
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 317: Africa Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Africa Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 319: Africa 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION